[The effect of hyaluronidase on the course of experimental atherosclerosis].
D000818:Animals; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D002199:Capillary Permeability; D002682:Chinchilla; D002784:Cholesterol / Q000097:blood; D005340:Fibrinogen / Q000097:blood; D006493:Heparin / Q000097:blood; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D007271:Injections, Intradermal; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D011817:Rabbits
D008055:Lipids; D008074:Lipoproteins; D005340:Fibrinogen; D006493:Heparin; D002784:Cholesterol; D006821:Hyaluronoglucosaminidase
Vliianie gialuronidazy na techenie eksperimental'nogo ateroskleroza.